Malignant progression is a life-threatening consequence of human papillomavirus-associated lesions. In this study, we tested the efficacy of papillomavirus early-gene-based vaccines for prevention of carcinoma development of papillomavirus-induced skin papillomas on rabbits. Rabbit skin papillomas were initiated by infection with cottontail rabbit papillomavirus (CRPV). The papillomas were allowed to grow for 3 months without any treatment intervention. Rabbits were then immunized by gene gun-mediated intracutaneous administration of four DNA plasmids encoding CRPV E1, E2, E6, and E7 genes, respectively. All eight control rabbits receiving vector alone developed invasive carcinoma within 8 to 13 months. In contrast, only two of eight vaccinated rabbits developed carcinoma at 12 and 15 months, respectively. Papilloma growth was suppressed in the majority of vaccinated rabbits but not completely eradicated. These results indicate that gene gun-mediated immunization with papillomavirus early genes may be a promising strategy for prevention of malignant progression of human papillomavirus-associated lesions in humans.High-risk human papillomaviruses (HPVs), such as HPV type 16 (HPV16) and HPV18, first induce benign mucosal and/or cutaneous hyperproliferative lesions that may spontaneously regress or persist and in some patients progress to invasive cancer (32). Epidemiological observations (3) together with those of a functional in vitro study of papillomavirus-encoded oncogenes (20) provide strong evidence that high-risk HPV infection plays a crucial role in the development of anogenital cancer, particularly cervical carcinoma, the second most common cancer in women worldwide. HPV infection is also linked to carcinoma development at other anatomical sites (29). Animal models of papillomavirus infection which mimic features of HPV-induced carcinoma are essential for studying immune responses to these virally induced cancers. One well-characterized model is the cottontail rabbit papillomavirus (CRPV) model (this virus infects cottontail rabbits, its natural host, and domestic rabbits). CRPV infection of New Zealand White (NZW) rabbits initially induces benign skin tumors (papillomas or warts) which may spontaneously regress or progress to invasive carcinoma (16). The natural history of CRPV-induced warts resembles that of human genital HPV infection (16). Recently, the CRPV-rabbit model has been used extensively for developing and testing papillomavirus early-gene-based (13, 14, 26, 31) and late-gene-based (4) vaccines. All these early studies tested the efficacy of vaccination for protection of animals against viral challenge. In our laboratory, rabbit skin warts induced by one CRPV isolate (CRPV-Hershey) showed a very low incidence of spontaneous regression (Ͻ2%) and developed invasive carcinoma on all rabbits with persistent virus infection within about 1 year (7). The model thus provides opportunities to test therapeutic vaccination against both benign (papilloma) and malignant (carcinoma) tumor cells. Our previo...